Dr. Kristian Andersen of Scripps Research Institute joins Cindy Lifer to discuss the dynamic interplay between viral evolution and the host immune system. Andersen recounts his non-traditional path into science, beginning with a PhD in T-cell immunology before transitioning to computational biology and viral genomics. He explains how genomic sequencing was used during the 2014 Ebola outbreak to confirm a single spillover event, thereby informing public health messaging. The conversation delves into the evolution of SARS-CoV-2, highlighting how selection pressures shifted from favoring inherent transmissibility in an immunologically naive population to favoring immune evasion as population immunity grew, culminating in variants like Omicron. Andersen discusses the anthropogenic drivers that increase pandemic risk, such as deforestation, live animal markets, and global travel. He expresses significant frustration with the post-pandemic rise of anti-science sentiment and the dismantling of public health infrastructure, calling on the scientific community to actively communicate and engage. The discussion also covers how viruses evolve within individual hosts, particularly during chronic infections, which likely serve as the origin for new variants.
A Tug-of-War: How Viruses Evolve Against the Immune System
0:32 A Non-Traditional Path to Science: Dr. Kristian Andersen discusses his journey from working at the post office in Denmark to pursuing a PhD in immunology at Cambridge, where he studied regulatory T-cells and the evolution of the transcription factor FoxP3.
7:48 From Immunology to Viral Genomics: Seeking a more data-driven field, Andersen moved into computational biology for his postdoc. His work involved using genomics to understand viral evolution, starting with Lassa virus and its interaction with human populations in West Africa.
12:01 Using Genomics to Guide Public Health: During the 2014 Ebola outbreak, Andersen’s team used genomic sequencing to demonstrate that the epidemic resulted from a single spillover event followed by human-to-human transmission. This data helped correct misinformation that people were still getting infected from animal markets, allowing officials to focus on proper hygiene and contact tracing.
17:52 The Shifting Evolution of SARS-CoV-2: The virus's evolution occurred in two main phases. Initially, in an immunologically naive population, it adapted for higher transmissibility. As population immunity from infection and vaccination grew, the selection pressure shifted to favor immune escape, leading to variants like Omicron.
23:28 Human Activity Drives Pandemic Risk: Andersen explains that factors like deforestation, encroachment on animal habitats, live animal markets in dense urban centers, and rapid global travel dramatically increase the opportunities for viruses to spill over from animals to humans and quickly spread worldwide.
31:18 Frustration with the Post-Pandemic Response: Andersen expresses deep concern that instead of learning from the COVID-19 pandemic, the world is seeing a rise in anti-vaccine and anti-science agendas, leading to the dismantling of public health agencies and a reduction in preparedness for the next pandemic.
38:47 A Call to Action for the Scientific Community: He argues that scientists and academic institutions must unite to combat misinformation. He stresses the need for scientists who engage with the public to be supported and rewarded by their institutions, as this communication is now a critical part of science.
43:25 How New Variants Emerge from Chronic Infections: Viruses constantly evolve within an infected individual. In chronic infections, such as those seen in immunocompromised patients with COVID-19, the virus faces continuous pressure from the immune system, creating a perfect environment for it to evolve significant changes and generate new variants.
49:09 The Future of COVID-19 Immunity: The population now has highly diverse immune histories (from different vaccines, boosters, and infection waves). This diversity makes it less likely for a single new variant to be as explosive as Omicron was. Andersen advocates for annual vaccination to continue broadening immunity and reducing the overall burden of disease.